KLINDASPECTIN® SOLUTION FOR INJECTION

1 ml contains 50 mg of clindamycin phosphate and 100 mg of spectinomycin dihydrochloride

Pharmacological properties

The combination of clindamycin and spectinomycin possesses a bacteriostatic effect against gram-positive and gram-negative microorganisms, including Staphylococcus spp., Streptococcus spp., Escherichia coli, Salmonella spp., Pasteurella multocida, Haemophilus spp., Proteus spp., Shigella spp., Klebsiella spp., Bordetella spp. and Mycoplasma spp. Mechanism of action: violation of protein synthesis in bacterial cell.

Indications

• Treatment of bacterial infections of respiratory system, gastrointestinal and urogenital tract, skin and soft tissues, caused by microorganisms, sensitive to clindamycin and spectinomycin, in calves.

Dosage

KLINDASPECTIN® SOLUTION FOR INJECTION is administered intramuscularly once a day at a dose of 1 ml of solution per 10 kg bw (i.e. 5 mg of clindamycin/kg bw and 10 mg of spectinomycin /kg bw) for 3-5 days.

Come back
Наверх